PL3487859T3 - Przeciwprzerzutowe 2h-selenofeno[3,2-H]chromeny, ich synteza i sposoby stosowania takich środków - Google Patents

Przeciwprzerzutowe 2h-selenofeno[3,2-H]chromeny, ich synteza i sposoby stosowania takich środków

Info

Publication number
PL3487859T3
PL3487859T3 PL16745850T PL16745850T PL3487859T3 PL 3487859 T3 PL3487859 T3 PL 3487859T3 PL 16745850 T PL16745850 T PL 16745850T PL 16745850 T PL16745850 T PL 16745850T PL 3487859 T3 PL3487859 T3 PL 3487859T3
Authority
PL
Poland
Prior art keywords
selenopheno
chromenes
antimetastatic
synthesis
methods
Prior art date
Application number
PL16745850T
Other languages
English (en)
Inventor
Pavels Arsenjans
Jelena VASILJEVA
Ilona Domracheva
Irina Shestakova
Ivars Kalvins
Original Assignee
Latvian Institute Of Organic Synthesis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvian Institute Of Organic Synthesis filed Critical Latvian Institute Of Organic Synthesis
Publication of PL3487859T3 publication Critical patent/PL3487859T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains three hetero rings
    • C07D517/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
PL16745850T 2016-07-21 2016-07-21 Przeciwprzerzutowe 2h-selenofeno[3,2-H]chromeny, ich synteza i sposoby stosowania takich środków PL3487859T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16745850.4A EP3487859B1 (en) 2016-07-21 2016-07-21 Antimetastatic 2h-selenopheno[3,2-h]chromenes, synthesis thereof, and methods of using same agents
PCT/IB2016/054341 WO2018015788A1 (en) 2016-07-21 2016-07-21 ANTIMETASTATIC 2H-SELENOPHENO[3,2-h]CHROMENES, SYNTHESIS THEREOF, AND METHODS OF USING SAME AGENTS

Publications (1)

Publication Number Publication Date
PL3487859T3 true PL3487859T3 (pl) 2021-07-19

Family

ID=56561392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16745850T PL3487859T3 (pl) 2016-07-21 2016-07-21 Przeciwprzerzutowe 2h-selenofeno[3,2-H]chromeny, ich synteza i sposoby stosowania takich środków

Country Status (12)

Country Link
US (1) US10561681B2 (pl)
EP (1) EP3487859B1 (pl)
JP (1) JP6779318B2 (pl)
AU (1) AU2016415412B2 (pl)
BR (1) BR112018073219B1 (pl)
CA (1) CA3029911C (pl)
DK (1) DK3487859T3 (pl)
EA (1) EA201990311A1 (pl)
ES (1) ES2849153T3 (pl)
PL (1) PL3487859T3 (pl)
UA (1) UA120083C2 (pl)
WO (1) WO2018015788A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV15485B (lv) * 2018-09-13 2020-06-20 Latvijas Organiskās Sintēzes Institūts Selenofēnhromenonu hidroksāmskābes, to izgatavošana un izmantošana angioģenēzes inhibīcijā
JP7648538B2 (ja) 2019-04-27 2025-03-18 ヘルス リサーチ インコーポレイテッド 前立腺癌の治療のためのクマリン修飾アンドロゲン
LV15558A (lv) 2019-08-28 2021-03-20 Latvijas Organiskās Sintēzes Institūts Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem
LV15575A (lv) 2019-12-20 2021-06-20 Latvijas Organiskās Sintēzes Institūts Selenofēnhromēnu deiterēti analogi, to iegūšana un izmantošana
CN112457330A (zh) * 2020-09-30 2021-03-09 浙江农林大学暨阳学院 一种珍珠光亮剂香豆素并苯并硒砜吩类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152210A2 (en) * 2008-06-12 2009-12-17 National Health Research Institutes Coumarin compounds and their use for treating cancer
US20090312406A1 (en) * 2008-06-12 2009-12-17 Hsing-Pang Hsieh Coumarin compounds and their use for treating viral infection

Also Published As

Publication number Publication date
AU2016415412B2 (en) 2019-07-11
EP3487859A1 (en) 2019-05-29
DK3487859T3 (da) 2021-04-19
JP2019523230A (ja) 2019-08-22
WO2018015788A1 (en) 2018-01-25
BR112018073219B1 (pt) 2020-06-16
US20190298758A1 (en) 2019-10-03
BR112018073219A2 (pt) 2019-01-22
US10561681B2 (en) 2020-02-18
JP6779318B2 (ja) 2020-11-04
ES2849153T3 (es) 2021-08-16
CA3029911A1 (en) 2018-01-25
EA201990311A1 (ru) 2019-07-31
UA120083C2 (uk) 2019-09-25
EP3487859B1 (en) 2021-01-20
AU2016415412A1 (en) 2018-11-08
CA3029911C (en) 2019-12-10

Similar Documents

Publication Publication Date Title
IL264049A (en) Compounds, preparations and methods for treating the disease
IL268988B (en) Solid formations of isoquinolinone derivatives, process for their preparation, compositions containing them and methods of use
IL264156A (en) Compounds, preparations and methods for treating the disease
IL262007A (en) Modified aminopurine compounds, their compositions and methods of treatment using them
PL3675854T3 (pl) Pochodne piperydynyloindolu do zastosowania w leczeniu glomerulopatii c3
EP3160940A4 (en) Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
HUE065438T2 (hu) Vegyületek, készítmények és alkalmazási eljárások
ZA201801301B (en) 1, 3, 5-triazine derivative and method of using same
EP3144292A4 (en) 2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
IL256350A (en) Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
EP3309138A4 (en) Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
HUE036789T2 (hu) Szintéziseljárás 1,2-benzizotiazolin-3-on elõállítására
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
ZA201902089B (en) Bryostatin compounds and methods of preparing the same
PT3604303T (pt) Novo derivado de pirrolopiridina, método para a produção do mesmo e utilizações do mesmo
DK3487859T3 (da) Antimetastatiske 2h-selenopheno[3,2-h]chromener, syntese deraf, og fremgangsmåder til brug af samme midler
IL272837A (en) A process for preparing tubolysins and their intermediates
AU2018345601B2 (en) Methods and compositions for inhibiting ADAM10 biological activities
EP3127903A4 (en) 2,2'-tandem dithiazole compound, preparation method therefor, and use thereof
EP3150584A4 (en) 3,4-dihydroquinazoline derivative and complex preparation containing same
IL251135A0 (en) A method for the synthesis of hydroxy-triglycerides and their use for the prevention and treatment of diseases
WO2016025473A3 (en) Synthesis of tetracyclic flavonoids
IL251323A0 (en) Author compounds, methods for their preparation and their use
EP3508486B8 (en) Aryl-2,2'-tandem bisthiazole compound and preparation method and use thereof